Recursion Pharmaceuticals News

Analysts Are Bullish on Top Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Recursion Pharmaceuticals (RXRX)

TipRanksApr 9 06:30 ET

Recursion Pharmaceuticals Analyst Ratings

BenzingaApr 9 06:18 ET

Recursion Pharmaceuticals Analyst Ratings

BenzingaMar 4 06:30 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Beam Therapeutics (BEAM), ACADIA Pharmaceuticals (ACAD) and Recursion Pharmaceuticals (RXRX)

TipRanksFeb 28 06:00 ET

Recursion Pharmaceuticals Analyst Ratings

BenzingaFeb 28 05:43 ET

Analysts Offer Insights on Healthcare Companies: Recursion Pharmaceuticals (RXRX) and Arcutis Biotherapeutics (ARQT)

TipRanksFeb 27 20:10 ET

Recursion Pharmaceuticals Analyst Ratings

BenzingaJan 26 11:33 ET

Recursion Pharmaceuticals Analyst Ratings

BenzingaJan 16 07:14 ET

Analysts Offer Insights on Healthcare Companies: Recursion Pharmaceuticals (RXRX), Edgewise Therapeutics (EWTX) and Eledon Pharmaceuticals (ELDN)

TipRanksNov 14, 2023 02:30 ET

JP Morgan Maintains Neutral on Recursion Pharmaceuticals, Lowers Price Target to $10

BenzingaNov 13, 2023 11:03 ET

Recursion Pharmaceuticals Analyst Ratings

BenzingaNov 13, 2023 11:02 ET

Needham Adjusts Recursion Pharmaceuticals Price Target to $15 From $17, Maintains Buy Rating

MT NewswiresNov 10, 2023 08:18 ET

Needham Maintains Buy on Recursion Pharmaceuticals, Lowers Price Target to $15

BenzingaNov 9, 2023 17:56 ET

Recursion Pharmaceuticals Analyst Ratings

BenzingaNov 9, 2023 17:54 ET

Strategic Partnerships and Robust Financial Status Bolster Buy Rating for Recursion Pharmaceuticals

TipRanksNov 9, 2023 13:57 ET

Recursion Pharmaceuticals (RXRX) Gets a Hold From Bank of America Securities

TipRanksSep 6, 2023 04:45 ET

Needham Reiterates Buy on Recursion Pharmaceuticals, Maintains $17 Price Target

BenzingaSep 5, 2023 10:38 ET

Recursion Pharmaceuticals Analyst Ratings

BenzingaSep 5, 2023 10:37 ET

Analysts Offer Insights on Healthcare Companies: Orchestra BioMed Holdings (OBIO), Anavex Life Sciences (AVXL) and Recursion Pharmaceuticals (RXRX)

TipRanksAug 8, 2023 10:50 ET

Recursion Pharmaceuticals Analyst Ratings

BenzingaJul 21, 2023 05:46 ET